History of gallbladder disease
According to Morningstar Equity Research, several other players, including Pfizer, Roche, Amgen AMGN, AstraZeneca AZN, Zealand Pharma ZLDPF, and Structure Therapeutics GPCR are expected to join in, with multiple drug launches anticipated between 2027 and 2032
S L-serinamide (L-serine with the carboxylic acid group replaced with a carboxamide)
After figuring out how to increase the amount of time exendin was active in the body, Eng, who worked at the Bronx Veterans Affairs Medical Center, created the first GLP-1: Exenatide
This combination helps maintain efficient cellular energy metabolism throughout the body
Funded by the South African Medical Research Council